In Vitro Diagnostic Devices: Update on ANVISA’s Petitioning System under RDC 830/2023
![In Vitro Diagnostic Devices: Update on ANVISA's Petitioning System under RDC 830/2023](https://qrgroup.com.br/wp-content/uploads/2024/09/In-Vitro-Diagnostic-Devices-Update-on-ANVISAs-Petitioning-System-under-RDC-8302023-1024x683.jpg)
QR Group provides guidance to international manufacturers on new regulatory requirements for in vitro diagnostic devices and how to adapt to RDC 830/2023 ANVISA will carry out an important update to its electronic petitioning system between May 29 and June 3 to comply with RDC 830/2023, which establishes new rules for the risk classification, registration, […]